Hypothermic effect of alpha-sympathomimetic agents and their antagonism by adrenergic and cholinergic blocking drugs.
D000316:Adrenergic alpha-Agonists / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000814:Aniline Compounds / Q000494:pharmacology; D000818:Animals; D001831:Body Temperature / Q000187:drug effects*; D002552:Cerebral Ventricles / Q000187:drug effects; D003000:Clonidine / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D007031:Hypothalamus / Q000187:drug effects; D007267:Injections; D007274:Injections, Intraperitoneal; D009278:Naphazoline / Q000494:pharmacology; D010080:Oxazoles / Q000494:pharmacology; D010109:Oxymetazoline / Q000494:pharmacology; D010276:Parasympatholytics / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D051381:Rats; D013238:Stereotaxic Techniques; D013565:Sympatholytics / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D013843:Thiazines / Q000494:pharmacology; D013997:Time Factors; D014052:Toluidines / Q000494:pharmacology; D014992:Xylenes / Q000494:pharmacology
D000316:Adrenergic alpha-Agonists; D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D000814:Aniline Compounds; D010080:Oxazoles; D010276:Parasympatholytics; D013565:Sympatholytics; D013843:Thiazines; D014052:Toluidines; D014992:Xylenes; D010109:Oxymetazoline; D009278:Naphazoline; D003000:Clonidine